Evan Loh serves as Executive at Paratek Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Evan Loh has executed 59 insider transactions totaling $2.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 19, 2017 involved exercising options for 39,478 shares valued at $169.8K.
Evan Loh currently holds 258,750 shares of Paratek Pharmaceuticals, Inc. (PRTK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Evan Loh has been a net seller of PRTK stock. They have purchased $98.6K and sold $2.6M worth of shares.
Evan Loh's most recent insider trade was on Jul 19, 2017, when they sold 39,478 shares at $4.30 per share.
Get notified when new Form 4 filings are submitted
| $23.58 |
| Discretionary |
| Jul 3, 2017 | PRTK | $0 | Award | 13,000 | $N/A | Discretionary |
| Feb 4, 2016 | PRTK | $0 | Award | 22,500 | $N/A | Discretionary |
| Dec 11, 2015 | PRTK | $15.0K | Purchase | 900 | $16.67 | Discretionary |
| Dec 10, 2015 | PRTK | $23.8K | Purchase | 1,400 | $17.00 | Discretionary |
| Nov 16, 2015 | PRTK | $59.8K | Purchase | 3,700 | $16.16 | Discretionary |
| Jun 30, 2015 | PRTK | $0 | Award | 30,000 | $N/A | Discretionary |
| Oct 30, 2014 | PRTK | $0 | Other | 44,389 | $N/A | Discretionary |